Physician profile
Jason Rodriguez
NPI 1093078339
$33,237.53
in general payments reported to CMS, 2019-2025
26 companies · $3,053 in 2025
The $3,053 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $4,785 · 2021: $1,577 · 2022: $751 · 2023: $1,420 · 2024: $1,586 · 2025: $3,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,460 · Travel and Lodging: $1,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,460.49 |
| Travel and Lodging | $1,598.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $12,883.03 | 2019-2020 | |
| Boston Scientific Corporation | $8,849.86 | 2019-2025 | Rhythmia Mapping System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Cardiofocus, INC. | $6,021.17 | 2019-2025 | Heartlight System |
| Abbott Laboratories | $3,682.06 | 2019-2025 | Aveir, Ensite, Ensite Precision |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $284.27 | 2021-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $276.79 | 2022-2025 | Optimizer, Optimizer |
| Biosense Webster, INC. | $216.37 | 2019-2024 | Carto 3 |
| Janssen Pharmaceuticals, INC | $130.39 | 2022-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $125.60 | 2022-2024 | |
| Cardiva Medical, INC. | $98.13 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 5f Vcs |
| Philips North America LLC | $95.97 | 2023 | |
| Sanofi-Aventis U.S. LLC | $89.58 | 2022-2024 | |
| Pfizer INC. | $74.33 | 2020-2025 | |
| Medtronic, INC. | $59.61 | 2021-2023 | Arctic Front Advance |
| Abiomed | $58.72 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.00 | 2022-2023 | Jardiance |
| Altathera Pharmaceuticals LLC | $45.90 | 2023 | Sotalol Hydrochloride |
| Kestra Medical Technology Services, INC. | $40.83 | 2024 | Assure Wcd |
| Vital Connect, INC | $27.53 | 2024 | Vitalpatch Rtm |
| Daiichi Sankyo INC. | $24.62 | 2023 | Injectafer |
| Elutia, INC. | $21.20 | 2022 | |
| Volta Medical INC | $19.29 | 2024 | Vx1 |
| Cordis US Corp. | $18.87 | 2024 | Mynx Venous Vcd |
| Lexicon Pharmaceuticals, INC. | $17.20 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $16.79 | 2024 | Brilinta |
| E.R. Squibb & Sons, L.L.C. | $13.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.